Efferon is a biotech company developing patented multimodal hemoadsorption technologies designed to remove endotoxins and inflammatory mediators directly from the bloodstream.

Designed for use in critical care settings, including sepsis and septic shock, Efferon’s technologies help stabilize hemodynamics and support organ function by addressing